Nanotechnology PPT| European Strategy| a European Strategy for Nanotechnology| Nanotechnology Research| Nanotechnology Industry: SlideWorld Medical PPT Search Engine.

A European strategy for Nanotechnology

Rating :

Rate It:

Send This

Download

Comment

Favourite

more

Notes

Show Notes

Slide 1 :

A European strategy for Nanotechnology Dr. Angela Hullmann European CommissionDG Research, Directorate ‘Industrial Technologies’Unit ‘Nanosciences and Nanotechnologies’ Conference on ‘Nanotechnology in Science, Economy, and Society’Marburg, Germany, 13th-15th January 2005

Slide 2 :

Why is nanotechnology important ? Analysts estimate that the market for products based on nanotechnology could rise to hundreds of billion by 2010 and exceed one trillion after

Slide 3 :

Nanotechnology Applications Expected to impact upon virtually all technological sectors as an “enabling” or “key” technology

Slide 4 :

Where do we stand in Europe? Enjoys a strong position in terms of producing knowledge in nanotechnology (e.g. publications) Weaker in transforming this knowledge into products and services (e.g. patents, start-ups) Europe already has a commercial deficit for high-tech products of around €23 billion per year Few “centres of excellence” on the scale of those being developed in other regions e.g. the USA Lower level of private R&D funding from industry in comparison to e.g. the USA and Japan

Slide 5 :

Worldwide funding of nanotechnology R&D Absolute public expenditure during 2003 (1€ = 1$) Public expenditure ( 1€ = 1$ ) Source: European Commission (2003)

Slide 6 :

1. Nanotechnologies and Nanosciences 2. Knowledge-based Multifunctional Materials 3. New Production Processes and Devices Thematic priority 3: NMP Total budget: € 1300 million Nanotechnology in the 6th Framework Programme

Slide 7 :

The economic objective of nanotechnology in the NMP priority is twofold: to promote the creation of an RTD-intensive European nanotechnology related industry and to promote the uptake of nanotechnologies in existing industrial sectors The social objectives are not less important: to promote the development of nanotechnology products and processes that help to solve health, environmental, and security problems to ensure that nanotechnology research and products will not harm health and/or the environment and do not break ethical rules Key objectives

Slide 8 :

COM(2004) 338 Nanotechnology:The European approach isintegrated and responsible InternationalCooperation Health, safety, environmental and consumer protection Recent Communication by the European Commission: “Towards a European strategy for nanotechnology” -> Nanotechnology R&D has to be embedded in a wider context and to follow a responsible approach

Slide 9 :

R&D: Building the Momentum European public investment in nanotechnology R&D should increase by a factor of 3 by 2010 Focus upon transforming our knowledge into wealth generating products and processes Reinforce the next Framework Programme for added-value via critical mass, transnational collaboration and competition Effective coordination of national programmes Bring public and private stakeholders together to strengthen roadmap and foresighting activities

Slide 10 :

Promote conditions that encourage investment in nanotechnology R&D by industry Investigate the prospects and conditions for the optimal industrial exploitation of nanotechnologies Invites the European Investment Bank and other institutions to strengthen the capital base for R&D Encourages closer cooperation between patent offices towards a more efficient patenting system Invites Member States to review existing regulation and consider specificities of nanotechnology Boost and coordinate actions in metrology, standards and norms Industrial Innovation: Knowledge to Technology

Slide 11 :

Infrastructure: European “Poles of Excellence” Europe needs a coherent system of infrastructure for R&D in nanotechnology Measures needed to maximise the added-value of existing infrastructure, in particular, to help SMEs Existing infrastructure should be examined and mapped to identify most urgent needs Where needed, dedicated Europe nanotechnology infrastructure with critical mass should be built All financing mechanisms should be explored e.g. European Investment Bank, Structural Funds, etc

Slide 12 :

Investing in Human Resources Identification of educational needs of nanotechnology and best practices Definition and implementation of new courses and curricula for nanotechnology Integration of complementary skills into research training (e.g. entrepreneurship) Exploration of dedicated Marie Curie calls for proposals in nanotechnology Creation of a “European award in nanotechnology” to encourage young researchers

Slide 13 :

Societal aspects Integration of societal aspects into nanotechnology R&D Open and proactive approach to governance in nanotechnology R&D A dialogue with EU citizens & consumers is encouraged to promote informed judgement The Commission reaffirms its commitment to ethical principles The responsible and transparent development of nanotechnology is essential for public confidence.

Slide 14 :

Nanotechnology in Science Fiction novels

Slide 15 :

The ‘tragedy’ of public engagement Consequences: Information and involvement of the public in an early stage of the development of an emerging technology is indispensable and policy has to be proactive A real partnership between science, society and policy has to be established, in form of an open dialogue with open results

Slide 16 :

How to communicate nanotechnology? Two projects are funded by the European Commission that aim at communicating ethical, legal and social aspects (ELSA) of research in nanotechnology to the public. One project bases on brochures, workshops and website tools, the other one on visualisation of nanotechnology in science museums and exhibitions.

Slide 17 :

ELSA of nanotechnology Nanologue: Questions that are addressed: Which aspects will be relevant in the future for public discussions about nanotechnology ? How can the public opinion be involved in future decision making in the field of nanotechnology ? How can scientists, researchers and entrepreneurs be sensitised for ELSA of nanotechnology? What are the hot topics for policy makers in general and for the European Research Policy in particular ?

Slide 18 :

Visualise nanotechnology Nano Dialogue: Questions that are addressed: How can the interested but ignorant public be informed about nanotechnology research ? How can the science base of nanotechnology be visualised ? How can young people be approached and attracted to nanotechnology ? How can a dialogue about ELSA of nanotechnology be provoked ?

Slide 19 :

Nanotechnology: informative materials Broschure: “Nanotechnology: Innovation for tomorrow’s world” Film (for younger people): “Nanotechnology” Film: “Nano: The next dimension” The brochure and the films can be obtained from www.cordis.lu/nanotechnology/src/pressroom.htm

Slide 20 :

Public Health, Safety, Environmental and Consumer Protection A high level of public health, safety, environmental and consumer protection requires: Identification of safety concerns (both real and perceived) and action at the earliest stage Toxicological and ecotoxicological data and evaluation of human/ environmental exposure Adjustment, if necessary, of risk assessment procedures for issues of nanotechnology Integration of risk assessment at all stages of the life cycle of the technology

Slide 21 :

Risk assessment between benefits and uncertainties The public acceptance an emerging technology depends on the perception of its (potential) risks in relation to its (potential) benefits. Both, risks and benefits, have to be made clear. Where uncertainties about potential dangers are occurring, research has to reduce these uncertainties. For the acceptance, it is irrelevant whether the risk perception is realistic or irrational.

Slide 22 :

Projects on risk assessment for health and environment Funded in the 5th Framework Programme (FP5): Nanosafe: Risk assessment in production and use of nanoparticles with development of preventive measures and practice codes Nanoderm: Skin as a barrier to ultra-fine particles Nanopathologies: nano-particles in biomaterial-induced pathologies FP6 – Projects in negotiation: Nanosafe II Toxicological impact of nanoparticles on human health and the environment FP6 – Next call for proposals: Interaction of engineered nanoparticles with the environment and the living world

Slide 23 :

A Further Step: International Co-operation Europe seeks international debate on issues such as public health, safety, environment, consumer protection, risk assessment, metrology, norms Europe insists that access to knowledge must stay open to all countries of this world; Europe even funds research of third countries (not of the wealthy though) Europe promotes the monitoring and sharing of information related to the scientific, technological, economical & social development of nanotechnology Europe strives to define an international “code of conduct” for the responsible development of nanotechnology.

Slide 24 :

Council of the European Union Endorsement of Commission's Communication ‘Towards a European strategy for nanotechnology’, namely to develop an integrated and responsible strategy The Commission's intention was welcomed: to draw up an Action Plan for nanotechnology (first quarter of 2005) after wide-ranging stakeholder debate to engage in dialogue at international level to establish a framework of shared principles for the safe, sustainable, responsible and socially acceptable development and use of nanotechnology.

Slide 25 :

General information on Nanotechnology in Europe: www.cordis.lu/nanotechnology Information For the European strategy for nanotechnology: www.cordis.lu/nanotechnology/src/communication For comments, questions or suggestions, please contact me: angela.hullmann@cec.eu.int

There is no comments now for this Slide.

Post a comment

Post Comment on Twitter Post Comment on SlideWorld

Comments:

Subscribe to follow-up comments

	SlidesOnline 1 Years ago. Category: Business

Tags:	Business

537 Views, 0 favourite
20 Apr 2005Core Business. Offering our customers competitive advantageOpens the field of interventi more 20 Apr 2005Core Business. Offering our customers competitive advantageOpens the field of interventional medicine under MRI (currently only …www.tril02.com/biph/biph-wnec.ppt less

SWINE Flu

Why do women live longer then men? Humor

History of Medicine

Yoga and Medicine

How to be a Successful Interventional Fellow size 50 MB

Cardiac Pathology

Hypertension: New Concepts, Guidelines, and Clinical Management

Diabetes Pathology